… Axiomer ® RNA editing technology platform and continued advancement of pipeline LEIDEN, Netherlands & CAMBRIDGE, … Officer of ProQR. “We look forward to continuing to advance our Axiomer RNA editing platform, with an initial … ® , which uses a cell’s own editing machinery called ADAR to make specific single nucleotide edits in RNA to …
… by ProQR. All of the shares are being offered by ProQR. In addition, ProQR has granted the underwriters a 30-day option to purchase up to 2,700,000 additional ordinary shares at the public offering price, less … Axiomer™, which uses a cell’s own editing machinery called ADAR to make specific single nucleotide edits in RNA to …
… there is currently no treatment,” said Dr. Bart Leroy, Head of the Ophthalmology Department and Professor of … ® , which uses a cell’s own editing machinery called ADAR (adenosine deaminase acting on RNA) to make specific …
… Annual General Meeting of Shareholders and Provides Leadership Updates Annual General Meeting of Shareholders to … ® , which uses a cell’s own editing machinery called ADAR (adenosine deaminase acting on RNA) to make specific …
… held in Q1 2023 Management Team appointments and planned additions to the Supervisory Board further strengthen leadership Repayment of debt with cash runway into 2026 … ® , which uses a cell’s own editing machinery called ADAR to make specific single nucleotide edits in RNA to …